Onkoloogiaravimid

Onkoloogiaravimid, also known as cancer drugs or chemotherapy drugs, are medications used to treat cancer. They work by targeting and killing cancer cells, or by slowing their growth and spread. These drugs can be administered in various ways, including orally, intravenously, or sometimes topically. The specific type of onkoloogiaravimid used depends on the type and stage of cancer, as well as the patient's overall health.

There are several major categories of onkoloogiaravimid. Cytotoxic chemotherapy drugs are the most common and work by damaging the DNA of rapidly dividing cells, including cancer cells. Targeted therapy drugs are designed to interfere with specific molecules that are involved in cancer cell growth and survival. Immunotherapy drugs help the patient's own immune system to recognize and attack cancer cells. Hormonal therapy drugs are used for cancers that are sensitive to hormones, such as breast and prostate cancer, by blocking or reducing hormone production.

The use of onkoloogiaravimid can lead to various side effects. These are often related to the drugs affecting healthy, rapidly dividing cells in the body, such as those in the bone marrow, hair follicles, and digestive tract. Common side effects can include fatigue, nausea, hair loss, and a weakened immune system. Many side effects can be managed with supportive care medications and treatments. Onkoloogiaravimid are a crucial part of many cancer treatment plans, often used alone or in combination with surgery, radiation therapy, or other treatments. The development and refinement of these drugs continue to improve outcomes for many cancer patients.